Hideki Sato
Sapporo, 0068585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia.
Journal: Infectious disease reports
Published: November 13, 2023
An Experimental Study on the Addition of Bacteria to Residual Anticancer Drugs: Evaluation of the Effect on Bacterial Growth.
Journal: Japanese journal of infectious diseases
Published: November 01, 2023
Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer.
Journal: In vivo (Athens, Greece)
Published: October 04, 2023
Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung Cancer.
Journal: In vivo (Athens, Greece)
Published: October 03, 2023
Association of Geriatric Nutritional Risk Index With Adverse Event and Treatment Duration in Adjuvant Chemotherapy for Patients With Colorectal Cancer.
Journal: In vivo (Athens, Greece)
Published: August 29, 2023
Case Report: Case series: association between blood concentration and side effects of sotorasib.
Journal: Frontiers in oncology
Published: July 31, 2023
The Relationship Between Efficacy and Safety of Osimertinib Blood Concentration in Patients With EGFR Mutation-positive Lung Cancer: A Prospective Observational Study.
Journal: In vivo (Athens, Greece)
Published: June 26, 2023
Association of Geriatric Nutritional Risk Index with Adverse Events and Time to Treatment Failure in Malignant Lymphoma Patients Treated with(R-)EPOCH
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 15, 2023
Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration-Time Curve in ICU Patients.
Journal: Antibiotics (Basel, Switzerland)
Published: May 24, 2023
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study.
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study.
Journal: In vivo (Athens, Greece)
Published: May 23, 2023
Influence of Geriatric Nutritional Risk Index on Occurrence of Adverse Events and Duration of Treatment in Patients With Lymphoma Receiving R-CHOP Therapy.
Journal: In vivo (Athens, Greece)
Published: March 01, 2023
Last Updated: 09/26/2026